LEVO-ALPHA-ACETYLMETHADOL (LAAM) VERSUS METHADONE: TREATMENT RETENTION AND OPIATE USE
Tallennettuna:
LONGSHORE, D., ET AL., LEVO-ALPHA-ACETYLMETHADOL (LAAM) VERSUS METHADONE: TREATMENT RETENTION AND OPIATE USE. ADDICTION, Vol. 100, no. 8 (2005), p. 1131-1139.
Ref.
135572
Sijainti:
SIIS R.696 Archivo
Palabras clave:
Alternativas, Drogas ilegales, Drogodependencias, Efectos, Evaluación de servicios, Fármacos, Metadona, Opiáceos, Programas de desintoxicación, Programas de mantenimiento, Reducción de daños, Tratamiento médico
Alternativas, Drogas ilegales, Drogodependencias, Efectos, Evaluación de servicios, Fármacos, Metadona, Opiáceos, Programas de desintoxicación, Programas de mantenimiento, Reducción de daños, Tratamiento médico
Samankaltaisia teoksia: LEVO-ALPHA-ACETYLMETHADOL (LAAM) VERSUS METHADONE: TREATMENT RETENTION AND OPIATE USE
- LEVO ALPHA ACETYLMETHADOL (LAAM) VERSUS METHADONE MAINTENANCE: 1 YEAR TREATMENT RETENTION, OUTCOMES AND STATUS
- THE USE OF LEVO-ALPHA-ACETYLMETHADOL (LAAM) IN METHADONE PATIENTS WHO HAVE NOT ACHIEVED HEROIN ABSTINENCE
- AN ASSESSMENT OF THE POTENTIAL CROSS-REACTIVITY OF LEVO-ALPHA-ACETYLMETHADOL (LAAM) WITH URINE ASSAYS FOR METHADONE
- METHADONE VS. L-ALPHA-ACETYLMETHADOL (LAAM) IN THE TREATMENT OF OPIATE ADDICTION
- LEVO-ALPHA ACETYL METHADOL (LAAM). ITS ADVANTAGES AND DRAWBACKS
- A RANDOMIZED TRIAL COMPARING LEVO-ALPHA ACETYLMETHADOL WITH METHADONE MAINTENANCE FOR PATIENTS IN PRIMARY CARE SETTING IN AUSTRALIA